Gastroenterology

Gastrointestinal (GI) clinicians are a critical touchpoint for individuals at risk for genetic and familial syndromes that increase risk of colorectal...

In a treat-to-target era, objective disease assessment in inflammatory bowel disease has become increasingly important. For many years, endoscopy has...

Acute-on-chronic liver failure (ACLF) represents a critical condition that may develop in patients with cirrhosis after an acute insult that is either...

Clostridioides difficile infection (CDI) is the most common health care–associated infection in the United States. The Centers for Disease Control and...

We read with interest the recent study by Norman et al1, entitled“Multi-HCC: A Practical Model to Prioritize Patients with Hepatocellular Carcinoma on...

We commend Norman et al1 for their innovative work on developing Multi-HCC, a model aimed at prioritizing patients with hepatocellular carcinoma (HCC)...

I would like to commend Norman et al1 for the well-conducted and thought-provoking study on the development of the Multi-HCC model to prioritize liver...

With interest, we read the phase 3 clinical trial report by Jeppesen et al,1 evaluating glepaglutide treatment for short bowel syndrome (SBS). This pi...

The phase 3 trial by Jeppesen et al,1 evaluating glepaglutide in reducing parenteral support (PS) for patients with short bowel syndrome (SBS) and int...

We have read with great interest the recent article by Jeppesen et al,1 regarding the efficacy and safety of glepaglutide in reducing parenteral suppo...